Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paul Lorigan"'
Autor:
Mark Middleton, Omid Hamid, Todd Bauer, Jessica Hassel, Friedegund Meier, Paolo Ascierto, John Kirkwood, Alexander Shoushtari, Marlana Orloff, April Salama, Paul Lorigan, Jeff Evans, Chris Holland, Shaad Abdullah, Cornelia Mauch, Ramakrishna Edukulla, Renee Mundy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/3a4461a2d25c43febc0bcaa2b6a0e695
Autor:
Paolo Antonio Ascierto, Eliana Rulli, Anna Cecilia Bettini, Maria Grazia Vitale, Carlo Alberto Tondini, Matilde De Luca, Barbara Merelli, Mario Mandala, Sharon Nahm, Paul Lorigan, Andrea Bianchetti, Lucia Bonomi, Giorgia Negrini, Andrea Di Croce
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Background In ambulatory patients with cancer with asymptomatic or pauci-symptomatic SARS-CoV-2 infection, the safety of targeted therapies (TTs), chemotherapy (CT) or immune checkpoint inhibitors (ICIs) therapy is still unknown.Material and methods
Externí odkaz:
https://doaj.org/article/5d142b23383c4287b8f38875db6c9331
Autor:
Martine Thomas, Gray Kueberuwa, John S. Bridgeman, Natalia Kirillova, Zachary J. Roberts, Ryan D. Guest, Yizhou Jiang, Paul Lorigan, Manon Pillai, Robert E. Hawkins, Fiona C Thistlethwaite
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundTumor infiltrating lymphocyte (TIL) products made from tumor digests showed a high overall response rate (ORR; 67%) and complete response (CR) rate (19%) and a safety profile consistent with lymphodepletion and high-dose interleukin (IL)-2
Autor:
Paolo A. Ascierto, Serigne Lo, Carlo Tondini, Richard D. Carvajal, Karijn P M Suijkerbuijk, Kerry L. Reynolds, Jessica S.W. Borgers, Jeremy Lupu, Christian U. Blank, Séverine Roy, Christian Posch, Michael Erdmann, Mario Mandalà, Ines Pires da Silva, Matteo S. Carlino, Maria Grazia Vitale, Tim Cooksley, F. Stephen Hodi, Megan H. Trager, Carola Berking, Leyre Zubiri, Laura Pala, Sharon Nahm, Dirk Schadendorf, Paola Queirolo, Alon Vaisman, Neha Papneja, Paul Lorigan, Joanna Mangana, Aljosja Rogiers, Alexander M. Menzies, Thiago Pimentel Muniz, Caroline Robert, Ryan J. Sullivan, John B. A. G. Haanen, Marcus O. Butler, Reinhard Dummer, Peter Bowling, Wilson H. Miller, Osama E. Rahma, Arielle Elkrief, Samuel D. Saibil, Chiara Tentori, Joseph M. Grimes, Michael Manos, Lisa Zimmer, Georgina V. Long, April A.N. Rose, Axel Hauschild
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer
Rogiers, A, Da Silva, I P, Tentori, C, Tondini, C A, Grimes, J M, Trager, M H, Nahm, S, Zubiri, L, Manos, M, Bowling, P, Elkrief, A, Papneja, N, Vitale, M G, Rose, A A N, Borgers, J S W, Roy, S, Mangana, J, Pimentel Muniz, T, Cooksley, T, Lupu, J, Vaisman, A, Saibil, S D, Butler, M O, Menzies, A M, Carlino, M S, Erdmann, M, Berking, C, Zimmer, L, Schadendorf, D, Pala, L, Queirolo, P, Posch, C, Hauschild, A, Dummer, R, Haanen, J, Blank, C U, Robert, C, Sullivan, R J, Ascierto, P A, Miller, W H, Stephen Hodi, F, Suijkerbuijk, K P M, Reynolds, K L, Rahma, O E, Lorigan, P C, Carvajal, R D, Lo, S, Mandala, M & Long, G V 2021, ' Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition ', Journal for ImmunoTherapy of Cancer, vol. 9, no. 1, e001931 . https://doi.org/10.1136/jitc-2020-001931
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
Journal for ImmunoTherapy of Cancer
Rogiers, A, Da Silva, I P, Tentori, C, Tondini, C A, Grimes, J M, Trager, M H, Nahm, S, Zubiri, L, Manos, M, Bowling, P, Elkrief, A, Papneja, N, Vitale, M G, Rose, A A N, Borgers, J S W, Roy, S, Mangana, J, Pimentel Muniz, T, Cooksley, T, Lupu, J, Vaisman, A, Saibil, S D, Butler, M O, Menzies, A M, Carlino, M S, Erdmann, M, Berking, C, Zimmer, L, Schadendorf, D, Pala, L, Queirolo, P, Posch, C, Hauschild, A, Dummer, R, Haanen, J, Blank, C U, Robert, C, Sullivan, R J, Ascierto, P A, Miller, W H, Stephen Hodi, F, Suijkerbuijk, K P M, Reynolds, K L, Rahma, O E, Lorigan, P C, Carvajal, R D, Lo, S, Mandala, M & Long, G V 2021, ' Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition ', Journal for ImmunoTherapy of Cancer, vol. 9, no. 1, e001931 . https://doi.org/10.1136/jitc-2020-001931
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
BackgroundPatients with cancer who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are more likely to develop severe illness and die compared with those without cancer. The impact of immune checkpoint inhibition (ICI) o
Publikováno v:
BMJ Case Reports
Parker, M, Roberts, M, Lorigan, P & Chinoy, H 2018, ' Autoimmune fasciitis triggered by the anti-programmed-cell-death-1 monoclonal antibody nivolumab ', BMJ Case Reports . https://doi.org/10.1136/bcr-2017-223249
Parker, M, Roberts, M, Lorigan, P & Chinoy, H 2018, ' Autoimmune fasciitis triggered by the anti-programmed-cell-death-1 monoclonal antibody nivolumab ', BMJ Case Reports . https://doi.org/10.1136/bcr-2017-223249
A 43-year-old woman with a history of recently diagnosed metastatic melanoma was commenced on systemic therapy with nivolumab, an anti-programmed cell death-1 monoclonal antibody and one of an increasing group of the so-called ‘immune checkpoint in